Global Biologics, Cell and Gene Legal Summit 2023

Practical Regulatory, Legal and Commercial Strategies for the Biologic Marketplace Across Europe, the US and Asia

Download the Agenda
Brussels, Belgium (BEL)
13-14 June, 2023

“This Global Biologics Cell and Gene Conference has been an extremely good forum for sharing views and address hop topics within the industry, I am glad I could spend the two days last week in Brussels with such a group of specialists. I am certainly looking forward to the next edition.”

Emmanuel Gougé, Partner, Pinsent Masons

WHY ATTEND

With many biologic patents set to lose exclusivity in 2023 a patent cliff is on the way. Generic, biosimilar and innovator biopharma companies are in different positions and will need to react differently to these changing market circumstances. Additionally, the face of biologics is changing with and increasing number of gene therapy and antibody-drug conjugate options adding to and sometimes taking the place of “naked antibodies”. The Global Biologics, Cell and Gene Summit is perfect place to address these changes with leading industry experts from across the IP, Regulatory and Commercial fields.

Highlights include:

  1. Understanding how the UPC will shape the future patent landscape for biologic products
  2. Discover the latest global perspective on the situation for biologics/biosimilars in Europe, US, and Asia.
  3. Understand the latest regulatory framework for biologic products.
  4. Learn the latest trends within the biologics marketplace with the commercial, regulatory and IP updates on Cell and Gene products.
100+
Attendees
30+
Executive Speaking Faculty
6
Individually Curated Roundtable Discussions
3
Regional Biologic Marketplaces

HOW TO GET INVOLVED

REGISTER YOUR INTEREST FOR 2024

Join us to network with colleagues and gain insights from industry experts on how you can create new innovative commercial and legal strategies, overcome market barriers, and take advantage of the growing opportunities in the biologic marketspace.

REGISTER YOUR INTEREST

PARTNER WITH US

Based on your objectives we can create bespoke packages especially for you.

From presenting your experience on stage to hosting networking drinks. You can partner with us to showcase your brand and make valuable new connections. Opportunities predominently lie in 3 main categories: Thought Leadership, Branding, and Networking.

Discuss your objectives with Duncan Henderson, Senior Commercial Partnerships Manager; [email protected] or register your your interest in sponsorship here: 

ENQUIRE ABOUT SPONSORSHIP

REGISTER YOUR INTEREST FOR 2024

We had a great time in June 2023 uncovering the latest global standings in the European, US, and Asian for biologics/biosimilars marketplaces with our community of some of the top in-house and private practice legal representatives.

Interested in joining next year? Fill out this quick form to register your interest and be the first to recieve our 2024 agenda when it's ready

 

From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick the "YES" box.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.


2023 Global Biologics, Cell and Gene Legal Summit

GLOBAL BIOLOGICS, CELL & GENE LEGAL SUMMIT 2023 COMMUNITY

From our advisory board and speaking faculty to our media and strategic partners, our series wouldn't be possible without the contributions of our esteemed community of in-house legal representatives, trademark/patent private practice lawyers and legal press

PARTNER WITH US

Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.

CONTACT US TO FIND OUT MORE

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

GLOBAL IP STRATEGY HUB ADVISORY BOARD

Author:

Lorenz Kallenbach

Senior Corporate Patent Counsel (Director)
Merck

Lorenz Kallenbach is a senior corporate patent counsel in the healthcare division of Merck KGaA. He is responsible for defining and executing the IP strategy for innovator projects. Including the assessment of the IP landscape, coordination of worldwide patent litigation, and portfolio development.

Before joining Merck, Lorenz worked in private practice. He is qualified as a German and European patent attorney.

Lorenz studied biochemistry and received a Ph.D. in the field of epigenetics.

Lorenz Kallenbach

Senior Corporate Patent Counsel (Director)
Merck

Lorenz Kallenbach is a senior corporate patent counsel in the healthcare division of Merck KGaA. He is responsible for defining and executing the IP strategy for innovator projects. Including the assessment of the IP landscape, coordination of worldwide patent litigation, and portfolio development.

Before joining Merck, Lorenz worked in private practice. He is qualified as a German and European patent attorney.

Lorenz studied biochemistry and received a Ph.D. in the field of epigenetics.

Author:

Stephan Kutik

Director, Intellectual Property
Genevant Sciences GmbH

Stephan Kutik

Director, Intellectual Property
Genevant Sciences GmbH

Author:

Nicolas Pourbaix

Associate General Counsel
Amgen

Nicolas Pourbaix

Associate General Counsel
Amgen

Author:

Christof Bull

Assistant General Patent Counsel
UCB

Christof Bull

Assistant General Patent Counsel
UCB

Author:

Alexandra Moulson

VP Development
Polpharma Biologics

Alex is an experienced leader and strategist with a broad background in marketing, product development, business development, portfolio management, and launch.

She has over 18 years of experience in pharmaceuticals, 8 years originators, 8 years biosimilars, and 2 years generics. Alex is British, with Biochemistry and MBA degrees.

Working backward, following her MBA, Alex was at McKinsey (reaching Associate Principal), at Morphosys was the Director for Business Development and at Sandoz brought a rituximab biosimilar to market and later led the Strategy Department for Sandoz. She is currently the Chief Development Officer for Polpharma Biologics.

Alexandra Moulson

VP Development
Polpharma Biologics

Alex is an experienced leader and strategist with a broad background in marketing, product development, business development, portfolio management, and launch.

She has over 18 years of experience in pharmaceuticals, 8 years originators, 8 years biosimilars, and 2 years generics. Alex is British, with Biochemistry and MBA degrees.

Working backward, following her MBA, Alex was at McKinsey (reaching Associate Principal), at Morphosys was the Director for Business Development and at Sandoz brought a rituximab biosimilar to market and later led the Strategy Department for Sandoz. She is currently the Chief Development Officer for Polpharma Biologics.

Author:

Mike Cottler

Ex Global Head of Litigation
Alvotech

Mike Cottler

Ex Global Head of Litigation
Alvotech

Author:

Dr. Leslie Fischer

Principal Patent Attorney
Sandoz

Leslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage. She speaks frequently at patent-related events and is an adjunct professor at Seton Hall Law School.

Dr. Leslie Fischer

Principal Patent Attorney
Sandoz

Leslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage. She speaks frequently at patent-related events and is an adjunct professor at Seton Hall Law School.

Author:

Ewan Nettleton

Principal IP Counsel, Oncology Litigation
Novartis Pharma AG

Ewan Nettleton

Principal IP Counsel, Oncology Litigation
Novartis Pharma AG

JOIN US IN BRUSSELS THIS YEAR

Venue

Le Louise Hotel Brussels, Avenue de la Toison d’Or, 40, B-1050 Brussels

This year's summit will be taking place at Le Louise Hotel Brussels 

Click here to claim a discounted room rate: EUR220 per night inc VAT and service
City tax excluded (EUR 4.24 per night per bedroom)

Discounted rate availble until 2nd June 2023

BOOK YOUR PLACE TODAY

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Preparing registration...

For more information on key datessponsorswebinars, virtual and in-person roundtables and other ways to get involved in the Global IP Series, download the 2023/2024 Marketing Solutions brochure below.

DOWNLOAD THE BROCHURE

If you have any questions, please get in touch and our Marketing team will get back to you.

CONTACT US

Global Biologics Cell & Gene Legal Summit Testimonials

Resources

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us